Cargando…

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies

Detalles Bibliográficos
Autores principales:	Gutfilen, Bianca, Valentini, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283428/ https://www.ncbi.nlm.nih.gov/pubmed/25587535 http://dx.doi.org/10.1155/2014/426892

Ejemplares similares

Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
por: Pisaneschi, Federica, et al.
Publicado: (2021)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
por: Sogbein, Oyebola O., et al.
Publicado: (2014)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017)

SPECT/CT and PET/CT, related radiopharmaceuticals, and areas of application and comparison
por: Alqahtani, Fawaz F.
Publicado: (2023)

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
por: Crișan, George, et al.
Publicado: (2022)

Special Issue “Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine”
por: Reischl, Gerald
Publicado: (2019)

PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments
por: Haubner, Roland, et al.
Publicado: (2014)

Editorial: Reviews in: Radiopharmaceuticals in nuclear medicine
por: Lau, Chuen-Yen, et al.
Publicado: (2023)

Insight into the Development of PET Radiopharmaceuticals for Oncology
por: Lau, Joseph, et al.
Publicado: (2020)

Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022)

Radiopharmaceutical Stem Cell Tracking for Neurological Diseases
por: Rosado-de-Castro, Paulo Henrique, et al.
Publicado: (2014)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review
por: Poletto, Giulia, et al.
Publicado: (2022)

Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016)

Development of a radiopharmaceutical dose calculator for pediatric patients undergoing diagnostic nuclear medicine studies
por: Pandey, Anil Kumar, et al.
Publicado: (2013)

Role of PET and SPECT in the Study of Amyotrophic Lateral Sclerosis
por: Cistaro, Angelina, et al.
Publicado: (2014)

Radiopharmaceuticals for PET imaging: issue A
por: Roivainen, Anne, et al.
Publicado: (2020)

Copper-64: a real theranostic agent
por: Gutfilen, Bianca, et al.
Publicado: (2018)

The present status of radiopharmaceuticals in the country
por: Jalilian, Amir Reza, et al.
Publicado: (2016)

Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bormans, Guy, et al.
Publicado: (2023)

Improving efficiency management of radiopharmaceutical materials at a nuclear medicine department
por: Al Ahmed, Ali, et al.
Publicado: (2015)

Stroma Targeting Nuclear Imaging and Radiopharmaceuticals
por: Shetty, Dinesh, et al.
Publicado: (2012)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

Nomenclature for radiopharmaceuticals, consultation of your opinion!
por: Elsinga, Philip H.
Publicado: (2017)

Metal-Based Radiopharmaceuticals in Inorganic Chemistry
por: Boschi, Alessandra, et al.
Publicado: (2023)

Evaluation of 99mtechnetium-radiopharmaceutical binding to blood elements using different trichloroacetic acid concentrations.
por: Freitas, R. S., et al.
Publicado: (1996)

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review
por: Eberlein, Uta, et al.
Publicado: (2011)

Recent Advances in Quantitative Nuclear Medicine and Molecular Imaging
por: Zhou, Yun, et al.
Publicado: (2018)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Development of PET and SPECT Probes for Glutamate Receptors
por: Fuchigami, Takeshi, et al.
Publicado: (2015)

Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
por: de Vries, E. F. J., et al.
Publicado: (2022)

A Projection-Domain Low-Count Quantitative SPECT Method for α-Particle-Emitting Radiopharmaceutical Therapy
por: Li, Zekun, et al.
Publicado: (2023)

PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
por: Auletta, Sveva, et al.
Publicado: (2019)

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
por: Evans, Brendan J., et al.
Publicado: (2020)

Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications()
por: Franquet, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4nh3vdm1pemnjm8pmq9jl0teb